Healthcare

  Bioinformatics Platform   Market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to register a CAGR of 14.7%.Key participants are involved in R&D of genetic and proteomic sequencing to improve DNA, RNA sequencing capabilities to further decrease the costs of genome sequencing. The development of next-generation sequencing technologies is projected to boost the bioinformatics industry during the forecast period. The report  " Global   Bioinformatics Platform Market, By Platform Type (Sequence Analysis Platform, Sequence Alignment Platform, Structural & Functional Analysis Platforms, and Others), By Application (Drug Development, Molecular Genomics, Gene Therapy, Personalized Medicines, and Others), By End-user (Academic & Research Institutes, Contract Research Organizations, and Biotechnology Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) -

  Medical Wearables Market accounted for US$ 13.2 billion in 2019 and is estimated to be US$ 104.9 billion by 2029 and is anticipated to register a CAGR of 23.3% Emerging economies such as India, China, and Brazil are projected to offer an extensive range of opportunities for players in the market. Moreover, the increasing adoption of mobile platforms, rising adoption of AI and 5G, and the growing awareness and preference for home healthcare will propel the growth of this market. The report  " Global   Medical Wearables Market, By Device (Diagnostic, Therapeutic, and Respiratory), By Type (Smartwatch and Patch), By Application (Sports and Fitness, Remote Patient Monitoring, and Home Healthcare), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: ·          In 2019, Apple, Inc., announced the ECG app on Apple Watch Series 4, a direct-to-consumer product that enables

  Pediatric vaccines are the vaccines used to prevent diseases such as pneumococcal disease, influenza, measles, mumps, and rubella and other diseases. The pediatric vaccines are given to the children up to a certain age to boost immunity against certain bacteria and virus. The pediatric vaccines market has attained maturity, in terms of some of the disease segments (like polio), for some diseases the vaccines are not yet developed, so the market for vaccines is not yet getting mature. The report  "   Global Pediatric Vaccines Market, By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, and Other Technologies), By Vaccine Type (Monovalent, and Multivalent), By Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR) and Other Applications), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 . The global pediatric vaccines market is growing up to the US $ 2.5